Form 5 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
[ ]Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.

[ ]Form 3 Holdings Reported

[ ]Form 4 Transactions Reported

ANNUAL STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940


1. Name and Address of Reporting Person
(Last) (First) (Middle)
Kruczlnicki David G.
(Street) (City) (State) (Zip Code)
Glens Falls Hospital

100 Park Street

Glens Falls, NY 12801
2. Issuer Name and Ticker or Trading Symbol
Arrow Financial Corporation (AROW)
3. IRS Identification Number of Reporting Person, if an Entity (Voluntary)
4. Statement for Month/Day/Year
12/31/02
5. If Amendment, Date of Original (Month/Year)
6. Relationship of Reporting Person(s) to Issuer (Check all applicable)
[x] Director
[ ] 10% Owner
[ ] Officer (title)
[ ] Other (specify)
7. Individual or Joint/Group Reporting (Check Applicable Line)
[X] Form filed by One Reporting Person

[ ] Form filed by More than One Reporting Person







Table I Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.

Title of Security

2.

Trans-

action

Date

(M/D/Y)

3.

Trans-

action

Code

4.

Securities

Acquired(A)

Disposed of(D)

5.

Amount of Securities Beneficially Owned at End

of Issuer's Fiscal Year

6.

Ownership

Form Direct

(D) or

Indirect (I)

7.

Nature

of Indirect

Beneficial

Ownership





Amount
(A)

or

(D)





Price
Common

Stock

12/02/02

12/05/02

12/13/02

B

G

R

22

500

158

A

D

A

$31.16

$31.73

$33.53

20,981 ESPP
Common

Stock

12/13/02

12/23/02

R

J(1)

4

8

A

A

$33.53

NA

617 DRIP
Common

Stock

12/23/02

12/23/02

R

J(1)

.06

8

A

D

$33.53

NA

0 DRIP
Common

Stock

12/13/02 R .4 A $33.53 58 DRIP with

Wife

Common

Stock

None 651 with Wife
Common

Stock

None 606


J(1) = Transfer shares

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned

(e.g., puts, calls, warrants, options, convertible securities)

1.

Title of

Derivative

Security

2.

Conversion

or Exercise

Price of

Derivative

Security

3.

Transaction

Date

(Mo/Da/Yr)

4.

Trans-

action

Code

5.

Number of

Derivative

Securities

Acquired

(A) or

Disposed

of (D)

6.

Date Exercisable

and Expiration Date

(M/D/Y)

(A) (D) Date

Exercisable

Expiration

Date

None


Table II (Continued)

1.

Title of

Derivative

Security

7.

Title and Amount of

Underlying Securities

8.

Price of

Derivative

Security

9.

Number of

Derivative

Securities

Beneficially

Owned at

End of Year

10.

Ownership

of Derivative

Security:

Direct (D) or

Indirect (I)

11.

Nature of

Indirect

Beneficial

Ownership

Title Amount or

Number of

Shares

None








Explanation of Responses:







Signature of Reporting Person









Gerard R. Bilodeau

Attorney in Fact

Date: 01/27/03